Clinical Journal of the American Society of Nephrology

Initial Changes in eGFR during Treatment with Balcinrenone and Dapagliflozin: An Exploratory Analysis of the MIRO-CKD Trial

By Hiddo J.L. Heerspink, Erika De Sousa Amorim, Jelle M. Beernink, Patrick Barry Mark

Trial in peopleInterventions

The paper

Hiddo J.L. Heerspink, Erika De Sousa Amorim, Jelle M. Beernink, Patrick Barry Mark

University Medical Center Groningen; University of Glasgow

Clinical Journal of the American Society of Nephrology, 17 Sep 2026

doi.org/10.2215/cjn.0000001202 PubMed 42752537

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance